Physician profile
Gavin Genzo Tsuchida
NPI 1902394083
$3,819.82
in general payments reported to CMS, 2019-2025
25 companies · $349 in 2025
The $349 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $2,655 · 2023: $563 · 2024: $253 · 2025: $349.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,165.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,164.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Elevate Surgical Co | $2,481.42 | 2022 | |
| Arthrex, INC. | $212.81 | 2023 | |
| Biotissue Holdings INC. | $178.66 | 2022-2023 | |
| Paratek Pharmaceuticals, INC. | $132.02 | 2022-2025 | Nuzyra |
| Smith+Nephew, INC. | $87.59 | 2024-2025 | Collagenase Santyl, Regranex, Stravix |
| Bioventus LLC | $76.56 | 2022-2025 | Exogen Ultrasound Bone Healing System, Exogen Ultrasound Bone Healing System |
| Djo, LLC | $72.00 | 2024-2025 | Procare, Aircast |
| Treace Medical Concepts, INC. | $49.85 | 2025 | |
| Vertex Pharmaceuticals Incorporated | $46.59 | 2024-2025 | |
| Aimmune Therapeutics, INC. | $44.62 | 2023 | |
| Depuy Synthes Sales INC. | $44.04 | 2025 | Na |
| Solventum Corporation | $43.69 | 2024-2025 | Activ.A.C., Promogran Prisma |
| Acera Surgical, INC. | $37.47 | 2022 | |
| Saxum Surgical, INC. | $36.45 | 2023 | |
| Ani Pharmaceuticals, INC. | $34.41 | 2025 | Purified Cortrophin Gel |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $32.62 | 2024-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Nevro Corp. | $30.50 | 2024 | Senza |
| Abbvie INC. | $29.44 | 2022 | |
| Mimedx Group, INC. | $29.41 | 2024 | |
| Organogenesis INC. | $27.55 | 2024 | |
| Stryker Corporation | $26.21 | 2025 | Variax, N/A, Easyfuse |
| Becton, Dickinson and Company | $24.44 | 2022 | |
| Kerecis Limited | $21.44 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Urgo Medical North America, LLC | $15.08 | 2025 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap, Drawtex Hydroconductive Wound Dressing With Levafiber 4x4, Urgok2 |
| Reprise Biomedical, INC. | $4.95 | 2023 | Miro3d |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gavin Tsuchida listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.